Liberty Mutual Group Asset Management’s AstraZeneca AZN Stock Holding History

Liberty Mutual Group Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-13,729	Closed	-$1.09M	–	98
2018 Q3	$1.09M	Buy	+13,729	New	+$1.04M	0.02%	342
2017 Q3	–	Sell	-14,284	Closed	-$974K	–	950
2017 Q2	$974K	Hold	14,284	–	–	0.04%	641
2017 Q1	$890K	Buy	+14,284	New	+$831K	0.03%	697
2016 Q4	–	Sell	-10,375	Closed	-$682K	–	1010
2016 Q3	$682K	Sell	10,375 -1,792	-15%	-$117K	0.02%	815
2016 Q2	$735K	Hold	12,167	–	–	0.03%	784
2016 Q1	$685K	Buy	+12,167	New	+$731K	0.03%	772
2015 Q4	–	Sell	-6,400	Closed	-$407K	–	982
2015 Q3	$407K	Buy	+6,400	New	+$421K	0.02%	1006
2015 Q1	–	Sell	-31,314	Closed	-$2.2M	–	1021
2014 Q4	$2.2M	Sell	31,314 -5,920	-16%	-$424K	0.07%	441
2014 Q3	$2.66M	Buy	+37,234	New	+$2.73M	0.09%	273

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Liberty Mutual Group Asset Management's AZN Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of AstraZeneca (AZN) in Q4 2018, closing a stake of 13,729 shares — an estimated $1.09M sold.

Liberty Mutual Group Asset Management first reported a position in AZN in Q3 2014 and held it in 9 quarters. The position peaked at $2.66M in Q3 2014. 557 funds tracked by Wall St. Rank hold AZN as of Q4 2018.

Liberty Mutual Group Asset Management reported no remaining AstraZeneca position as of Q4 2018 after selling out during the quarter.
Liberty Mutual Group Asset Management sold 13,729 AstraZeneca shares in Q4 2018, an estimated $1.09M.
Liberty Mutual Group Asset Management first reported a position in AstraZeneca in Q3 2014 and held it in 9 quarters.
Liberty Mutual Group Asset Management's AstraZeneca position peaked at $2.66M in Q3 2014.
557 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.